Benzofuran and benzothiophene derivatives useful in the treatment of hyperproliferative disorders

Details for Australian Patent Application No. 2003213219 (hide)

Owner Bayer Pharmaceuticals Corporation

Inventors Hatoum-Mokdad, Holia; Dumas, Jacques; Fan, Dongping; Zhang, Chengzhi; Lee, Wendy; Fan, Jianmei; Burke, Michael; Ladouceur, Gaetan; Chen, Zhi; Phillips, Barton; Jones, Benjamin, D.

Agent Davies Collison Cave

Pub. Number AU-B-2003213219

PCT Number PCT/US03/05396

PCT Pub. Number WO2003/072561

Priority 60/359,011 22.02.02 US; 60/399,886 31.07.02 US

Filing date 21 February 2003

Wipo publication date 9 September 2003

Acceptance publication date 26 February 2009

International Classifications

C07D 307/82 (2006.01) Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

A61K 31/343 (2006.01) - condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone

A61K 31/353 (2006.01)

A61K 31/357 (2006.01) - having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel

A61K 31/36 (2006.01)

A61K 31/381 (2006.01) - having five-membered rings

A61K 31/422 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/427 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/4355 (2006.01)

A61K 31/443 (2006.01)

A61K 31/4436 (2006.01)

A61K 31/455 (2006.01) - Nicotinic acid, i.e. niacin

A61K 31/497 (2006.01)

A61P 13/08 (2006.01) Drugs for disorders of the urinary system

A61P 13/10 (2006.01) Drugs for disorders of the urinary system

A61P 35/00 (2006.01) Antineoplastic agents

A61P 35/02 (2006.01) Antineoplastic agents

A61P 35/04 (2006.01) Antineoplastic agents

B66F 3/36 (2006.01) Devices, e.g. jacks, adapted for uninterrupted lifting of loads

C07D 307/92 (2006.01) Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

C07D 307/93 (2006.01) Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

C07D 333/66 (2006.01) Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

C07D 333/74 (2006.01) Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

Event Publications

24 July 2003 Complete Application Filed

  Priority application(s): 60/359,011 22.02.02 US; 60/399,886 31.07.02 US

16 October 2003 Application Open to Public Inspection

  Published as AU-B-2003213219

26 February 2009 Application Accepted

  Published as AU-B-2003213219

25 June 2009 Standard Patent Sealed

15 April 2010 Assignment Registered

  Bayer Pharmaceuticals Corporation The patent has been assigned to Bayer HealthCare LLC

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003213220-COSMETIC FORMULATIONS CONTAINING L-ARGININE OLIGOMERS

2003213218-System and method for channel quality feedback